Cresco Labs (CRLBF) Accounts Payables (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Accounts Payables came in at $14.2 million in Q1 2026, down 14.31% on a QoQ basis from $16.5 million in Q4 2025.
Cresco Labs (CRLBF) Accounts Payables (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Accounts Payables data on file, last reported at $14.2 million in Q1 2026.
- Quarterly Accounts Payables changed N/A year-over-year to $14.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.2 million (changed N/A YoY) and the FY2025 annual result came in at $16.5 million, changed N/A from the prior year.
- Accounts Payables slipped to $14.2 million in Q1 2026, from $16.5 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $33.3 million in Q1 2022 to a low of $14.2 million in Q1 2026.
- A 5-year average of $21.0 million and a median of $18.8 million in 2024 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 10.04% in 2022, down 10.04% in 2022.
- Tracing CRLBF's Accounts Payables over 5 years: stood at $33.3 million in 2022, then fell by 17.12% to $27.6 million in 2023, then slumped by 30.57% to $19.2 million in 2024, then decreased by 13.65% to $16.5 million in 2025, then slipped by 14.31% to $14.2 million in 2026.
- The last three Accounts Payables figures came in at $14.2 million (Q1 2026), $16.5 million (Q4 2025), and $19.2 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 356.00 Mn |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn | 16.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.17 Mn |
| Dec 31, 2025 | 16.54 Mn |
| Sep 30, 2024 | 19.16 Mn |
| Jun 30, 2024 | 18.79 Mn |
| Mar 31, 2024 | 17.40 Mn |
| Dec 31, 2023 | 27.59 Mn |
| Mar 31, 2022 | 33.29 Mn |
| Dec 31, 2021 | 32.28 Mn |
| Sep 30, 2021 | 25.62 Mn |
| Mar 31, 2021 | 37.00 Mn |
| Dec 31, 2020 | 23.23 Mn |
| Dec 31, 2019 | 62.83 Mn |